ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,774Medicare Part D Prescriptions Filled, Including Refills

Rank: 134 out of 680

$869K Total Retail Price of All Prescriptions

Rank: 113 out of 680

552 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 552 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

14% of this provider’s 552 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 11,229 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LISINOPRIL 451 339 1 5
LEVOTHYROXINE SODIUM 370 329 2 2
SIMVASTATIN 364 315 3 3
AMLODIPINE BESYLATE 356 272 4 1
FUROSEMIDE 350 312 5 6
NAMENDA 322 310 6 35
METOPROLOL TARTRATE 308 290 7 12
OMEPRAZOLE 302 243 8 7
PRAVASTATIN SODIUM 281 210 9 10
HYDROCODONE-ACETAMINOPHEN 270 183 S3 10 4
TRAMADOL HCL 266 219 11 18
DONEPEZIL HCL 262 262 12 27
METOPROLOL SUCCINATE 250 190 13 13
ATORVASTATIN CALCIUM 245 189 14 11
GABAPENTIN 210 165 15 15
CITALOPRAM HBR 209 168 16 22
LOSARTAN POTASSIUM 197 152 17 21
METFORMIN HCL 195 162 18 8
WARFARIN SODIUM 179 148 19 20
TRIAMTERENE-HCTZ 179 159 19 52
LISINOPRIL-HYDROCHLOROTHIAZIDE 176 138 21 37
FINASTERIDE 167 131 22 109
QUETIAPINE FUMARATE 159 121 23 64
CARVEDILOL 157 139 24 23
TAMSULOSIN HCL 157 136 24 34
ALENDRONATE SODIUM 148 133 26 32
ATENOLOL 143 106 27 19
ALLOPURINOL 129 97 28 33
CARBIDOPA-LEVODOPA 122 121 29 117
ISOSORBIDE MONONITRATE ER 121 121 30 59
LOSARTAN-HYDROCHLOROTHIAZIDE 109 98 31 51
FENOFIBRATE 107 69 32 66
KLOR-CON M10 104 104 33 127
HYDROCHLOROTHIAZIDE 103 78 34 9
NAPROXEN 101 66 35 121
CLOPIDOGREL 95 88 36 26
METHYLPREDNISOLONE 93 71 37 93
MELOXICAM 83 78 38 24
TIZANIDINE HCL 81 56 39 140
ALPRAZOLAM 81 64 39 72
FLUOXETINE HCL 80 69 41 74
POTASSIUM CHLORIDE 79 72 42 14
DIOVAN 75 74 43 31
NEXIUM 75 45 43 16
PLAVIX 73 71 45 39
GLYBURIDE-METFORMIN HCL 72 60 R 46 107
DETROL LA 71 62 47 169
SERTRALINE HCL 71 39 47 28
DIOVAN HCT 70 54 49 55
ETODOLAC 69 47 50 206
SULFAMETHOXAZOLE-TRIMETHOPRIM 69 58 50 94
ZOLPIDEM TARTRATE 69 56 50 17
METFORMIN HCL ER 68 61 53 54
MIRTAZAPINE 67 57 54 78
INSULIN SYRINGE 66 50 55 86
ZOSTAVAX 65 60 56 230
LEVETIRACETAM 64 45 57 120
SPIRIVA 63 58 58 70
OLANZAPINE 63 63 58 116
DIVALPROEX SODIUM 63 43 58 110
RANITIDINE HCL 62 50 61 56
TEMAZEPAM 60 50 62 155
PREDNISONE 60 53 62 50
NOVOLOG MIX 70-30 FLEXPEN 59 43 64 289
CYMBALTA 57 31 65 46
SEROQUEL 57 47 65 123
IBUPROFEN 57 44 65 126
AMITRIPTYLINE HCL 57 38 R 65 47
ADVAIR DISKUS 56 47 69 53
TRAZODONE HCL 55 46 70 48
CIPROFLOXACIN HCL 55 47 70 57
POLYETHYLENE GLYCOL 3350 55 49 70 62
BACLOFEN 54 27 73 140
HUMALOG MIX 75-25 53 34 74 268
ORPHENADRINE CITRATE 52 42 R 75 358
SPIRONOLACTONE 52 50 75 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.